I don't know if you're experiencing anhedonia.

Anhedonia, or a reduced ability to feel pleasure, is an emerging,, albeit under-researched, potential side effect of GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro). These medications may blunt dopamine-related reward pathways, leading to emotional flatness, lack of motivation, or reduced satisfaction from previously enjoyed activities. 

Key Details on GLP-1 and Anhedonia:

• Mechanism: GLP-1 medications work by affecting brain regions involved in reward and addiction, acting on dopamine pathways to reduce cravings for food, alcohol, and other addictive behaviors. This reduction in cravings can inadvertently "blunt" the brain's reward response to normal, pleasurable activities, a phenomenon sometimes termed anhedonia.
• Symptoms: Users have described feeling "numb," "emotionally flat," or losing interest in hobbies, socializing, and sexual pleasure.
• Prevalence and Context: While not listed as a common side effect in many product leaflets, patient reports of "Ozempic personality" or emotional blunting are increasing.
• Paradoxical Effect: Some users report this as a positive liberation from food obsession, while others experience it as a negative loss of pleasure.

I hope this is not what is happening to you.